For the quarter ending 2026-03-31, SEAT had $40,853K increase in cash & cash equivalents over the period. $45,984K in free cash flow.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Write-off of sponsorship loan | - | 0 | 0 | -2,024 |
| Net loss | -14,631 | -428,662 | -19,713 | -273,115 |
| Adjustment of liabilities under tra | - | -932 | -615 | -149,172 |
| Depreciation and amortization | 12,308 | 11,703 | 13,723 | 23,966 |
| Impairment charges | - | 402,574 | 0 | 320,449 |
| Amortization of leases | -356 | -349 | -445 | -720 |
| Amortization of deferred financing costs | 235 | 235 | 250 | 485 |
| Equity-based compensation | 4,414 | 2,848 | 11,483 | 22,403 |
| Loss on asset disposals | -59 | -175 | -184 | -196 |
| Change in fair value of derivative asset | -196 | -1,360 | -268 | -573 |
| Deferred income tax benefit | -1,206 | -2,040 | 79 | 76,707 |
| Non-cash interest income - net | - | 651 | - | - |
| Non-cash interest expense - net | -357 | - | 165 | 334 |
| Foreign currency loss (gain) - net | -806 | -2,237 | -1,211 | 3,574 |
| Change in fair value of intermediate warrants | 0 | -211 | -864 | -4,849 |
| Change in fair value of contingent consideration | - | 0 | - | - |
| Loss on extinguishment of debt | 0 | 0 | 0 | -801 |
| Accounts receivable - net | 5,833 | -7,518 | -10,933 | 906 |
| Inventory - net | 10,713 | -5,401 | -9,051 | 13,018 |
| Prepaid expenses and other current assets | 7,558 | 434 | -2,641 | -3,613 |
| Accounts payable | 71,479 | -45,221 | -4,848 | -29,394 |
| Accrued expenses and other current liabilities | -2,680 | 3,824 | -11,507 | -28,104 |
| Deferred revenue | -828 | 1,850 | -1,855 | -3,826 |
| Long-term lease liabilities | -586 | -571 | -646 | -1,085 |
| Other non-current assets and liabilities | -47 | 358 | 9,873 | -864 |
| Net cash provided by (used in) operating activities | 46,007 | -38,203 | 512 | -53,908 |
| Purchases of seat images | - | 919 | - | - |
| Disbursement of sponsorship loan | - | 0 | 0 | - |
| Purchases of property and equipment | 23 | 111 | 10 | 2,043 |
| Purchases of personal seat licenses | 384 | -7 | 30 | 960 |
| Investments in developed technology | 2,677 | 3,575 | 4,192 | 8,341 |
| Purchases of seat images | -666 | - | 365 | 321 |
| Payments toward acquired domain name obligation | 0 | 0 | - | - |
| Transfer of cash consideration during 2023 acquisitions, net of cash acquired | - | 0 | - | - |
| Mergers and exchange of class b common stock for class a common stock in connection with corporate simplification | - | 1,621 | - | - |
| Investment in note and warrant | - | 0 | - | - |
| Repurchase and retirement of fractional shares resulting from reverse stock split value | - | 0 | -5 | - |
| Net cash used in investing activities | -3,104 | -3,912 | -4,597 | -11,665 |
| Tax distributions to redeemable noncontrolling interests | - | 0 | 0 | 1,689 |
| Payments of loan-Two Thousand Twenty Two First Lien Loan | - | 0 | 0 | 0 |
| Proceeds from 2024 first lien loan-Two Thousand Twenty Five First Lien Loan | - | 0 | 0 | 76,986 |
| Payments for taxes related to net settlement of equity incentive awards | 338 | 38 | 106 | 1,742 |
| Payments of shoko chukin bank loan | - | 0 | 0 | 0 |
| Payments of loan-Two Thousand Twenty Five First Lien Loan | 983 | 984 | 981 | 983 |
| Proceeds of loan-Two Thousand Twenty Four First Lien Loan | - | 0 | 0 | 0 |
| Payments of acquired domain name obligation | 500 | 500 | 500 | 1,000 |
| Repurchases of class a common stock | 0 | 3 | 2,430 | 15,862 |
| Payments of liabilities under tra | 0 | 0 | 0 | -4,005 |
| Payments of loan-Two Thousand Twenty Four First Lien Loan | 0 | 0 | 0 | 76,986 |
| Proceeds from 2025 first lien loan | 0 | - | - | - |
| Cash paid for milestone payments | - | 0 | - | - |
| Payments of deferred financing costs and other debt-related expenses | 0 | 0 | 0 | 162 |
| Net cash used in financing activities | -1,821 | 96 | -4,022 | -25,443 |
| Effect of exchange rate changes on cash, cash equivalents, and restricted cash | -229 | -388 | -166 | 354 |
| Net increase (decrease) in cash, cash equivalents, and restricted cash | 40,853 | -42,407 | -8,273 | -90,662 |
| Cash, cash equivalents, and restricted cash - beginning of period | 103,306 | 145,713 | 244,648 | - |
| Cash, cash equivalents, and restricted cash - end of period | 144,159 | 103,306 | 145,713 | - |
Vivid Seats Inc. (SEAT)
Vivid Seats Inc. (SEAT)